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Abstract
Microbial infections can happen on a daily basis. There are specific microbial infections
that are associated with the reproductive health. Infertility is a devastating health prob‐
lem. It is estimated that out of 15% of infertility worldwide, around 50% is due to male
partner. Infections due to Chlamydia trachomatis, Mycoplasma genitalium, hepatitis B virus,
tuberculosis, Streptococcus faecalis, and mumps are found to be associated with male infer‐
tility. Although most of the life-threatening microbial infections have dramatically de‐
clined since the introduction of the childhood vaccination program, there are concerns
about few outbreaks and the associated risk of male infertility. This chapter deals with
few microbial infections, their association with male infertility, prevention, symptoms, di‐
agnosis, treatment, and control measures.
Keywords: Microbial infections, male infertility, genital infections, Streptococcus faecalis,
Chlamydia trachomatis, Mycoplasma genitalium
1. Introduction
With enormous growth of population, India ranks second in world with 1.28 billion. Rather
population growth is a major concern, yet infertility is a devastating health problem. According
to World Health Organisation (WHO), infertility is the inability of the female partner to attain
pregnancy after 1 year or more of the unprotected sex. Infertility affects about 15% of the couple
of which half of the reproductive problems are associated with the male counterpart [1]. Many
factors, including genetic causes, intoxication, microbial infections in genital tract, changes in
lifestyle, stress, and the recent trend of late marriages, contribute to this occurrence. Table 1
highlights infertility due to male genital infections. Despite enormous progress in the under‐
standing of human reproductive physiology, the underlying cause of male infertility remains
undefined in about 50% of cases, which are referred to as idiopathic infertility [2, 3].
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STD:Chlamydia trachomatis and Mycoplasma genitalium
Urinary tract: Streptococcus faecalis
Orchitis: Small pox, mumps, measles, and tuberculosis
Damaging spermatozoa: Hepatitis B viral infection
Table 1. Male genital tract infections that may cause infertility
2. Rationale
Globally, 5.0–7.0% of the general male population was affected by infertility and the trend may
increase in the future, considering the apparent decline of sperm count in industrialized
countries [4]. Male infertility, a multifactorial complex disease, has been a source of concern
in India lately. Recent statistics reports that the percentage of male infertility has elevated to
60% now against 40% in 1980s (New Indian express, 2015). The magnitude of the problem calls
for urgent action, particularly when the infertility is avoidable in the majority of cases.
3. Causes of male infertility
Primary (when no pregnancy has ever occurred) and secondary (there has been a pregnancy,
regardless of the outcome) infertility are the two forms of infertility. The former is found in
67–71% and latter in 29–33% of patients, respectively. Approximately 50% of the infertility is
due to male of which 30% is due to male factors and 20% with both male and female factors.
However, in approximately 30% of cases, the origins of reduced male infertility are unknown
called as idiopathic. Male infertility has been associated with several genetic and nongenetic
conditions.
3.1. Molecular genetics of male infertility
Genetic abnormalities, such as numerical and structural chromosomal abnormalities, were
identified in men with unexplained oligozoospermia and azoospermia [5]. Chromosomal
disorders, mitochondrial DNA (mtDNA) mutations, monogenic disorders, and multifactorial
disorders are the genetic factors involved in male infertility.
3.1.1. Chromosomal disarrays
Renowned chromosomal abnormalities, such as Klinefelter syndrome (XXY) and specific
translocations are well-documented causes of male infertility [6]. Point mutations in the
androgen receptor and the cystic fibrosis transmembrane conductance regulator (CFTR) gene
commonly associated with congenital vas deferens abnormalities are the two important gene
defects conclusively associated with spermatogenic failure.[7]
Genital Infections and Infertility84
3.1.1.1. Y chromosome microdeletion
Microdeletion of the long arm of the Y chromosome (Yq) is one of the prominent causes of
male infertility. It was shown by 13% of azoospermic men, 1–7% of severely oligozoospermia
men, and 5% of men with severe primary testicular failure and with a sperm density of less
than 5 million/mL [6]. Recombination events between long stretches of highly repetitive DNA
sequences during meiosis or early preimplantation development cause de novo deletions of
Yq [8]. Intracytoplasmic sperm injection (ICSI), an artificial reproduction technique, may allow
for the transmission of Y chromosome microdeletions to the next generation [9].
3.1.1.2. Mutations in Mitochondrial DNA
Mitochondria have their own genome, capable of producing many essential components of
the respiratory chain, which in turn have a profound blow on sperm motility. Environmental
and genetic factors may affect the quality and quantity of sperm production. Adenosine
triphosphate (ATP) production by sperm mitochondria is essential because of the high demand
of energy for these cells [10].
3.1.1.3. Monogenic disorders
Monogenic genetic disorders are an inherited disease controlled by a single pair of genes. Such
disorders are inherited in a simple pattern according to Mendel’s laws. Male infertility is
associated with 50 monogenic disorders.
3.1.1.4. Complex or multifactorial disorders
Complex or multifactorial disorders result from mutations in multiple genes, often together
with environmental causes. A mutation (C677T) in the gene, methylenetetrahydrofolate
reductase (MTHFR), is known to increase susceptibility to various multifactorial disorders [11].
3.2. Nonheritable causes of male infertility
Nonheritable causes include genital infections, hypogonadotrophic hypogonadism, testicular
maldescence, structural abnormalities of the male genital tract (obstruction of spermatic ducts,
agglutination of sperm), impotency, previous scrotal or inguinal surgery, varicoceles, chronic
illness, medication, exposure to chemicals, environmental factors, and immunological causes.
3.2.1. Hormonal causes
Fertility is questioned when endocrine system is affected on exposure to certain environmental
compounds. Elevated concentrations of luteinizing hormone (LH) and follicle-stimulating
hormone and low concentrations of gonadal steroids cause gonadal failure, a reason for
infertility. In the male, elevated concentrations of LH can result from hypergonadotrophic
hypogonadism (HH), which could be due to various reasons, such as primary testicular failure,
seminiferous tubule dysgenesis (Klinefelter syndrome), Sertoli cell failure, and anorchia [12].
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3.2.2. Hypogonadotrophic hypogonadism
Patients with this condition show decreased levels of gonadotrophins.
3.2.3. Erectile dysfunction
Of all males are affected by impotence or erectile dysfunction and can be emotionally and
psychologically disabling for men and their partners; 80% of erectile dysfunction cases may
be due to physical factors, such as drugs, blood flow abnormalities, nerve impulse abnormal‐
ities, and hormonal abnormalities. Remaining cases may be due to psychological factors and
may be attributed to stress, performance anxiety, or misinformation about sexuality.
3.2.4. Previous scrotal or inguinal surgery
Gonorrhea and chlamydia cause acute inflammation of the scrotal contents (usually unilateral)
in young men. Painless swellings in the scrotum are common. Most of these are small, round,
epididymal cysts, or spermatoceles, and no investigation or treatment is required [13]
3.2.5. Varicocele
Varicocele, a condition of palpably distended veins of the pampiniform plexus of the spermatic
cord, is the most common identifiable cause of male subfertility [14].Varicoceles feel like a bag
of worms in the scrotum and can be associated with infertility [13]. “Subclinical varicocele”
refers to a lesion too small to be detected by physical examination.
3.2.6. Exposure to chemicals
Various chemicals have been implicated as reproductive toxicants. Air pollutants are present
in the blood, urine, and semen of exposed men and may affect sperm quality [15]. Sperm
function tests have shown that high lead levels in semen samples reduce the ability of the
sperm to bind to the egg and also to penetrate and fertilize the egg.
3.2.7. Environmental factors
Decreasing human sperm concentrations worldwide is alarming fact. Sperm morphology is
affected by occupational heat exposure, which is a significant risk factor for male infertility,
resulting in delayed conception. The male reproductive system is particularly vulnerable to
the effects of the chemical and physical environment. This may be due to dramatic events or
to endemic conditions of the environment, which involves industrial and agricultural pollu‐
tion. Idiopathic male infertility may be due to exposure to environmental toxicants that alter
the reproductive hormones, spermatogenesis, or sperm function. Semen quality has been
shown to be altered on exposure to environmental ozone [16]. Environmental reproductive
hazard studies report that sperm counts have declined in certain industrialized countries.
3.2.8. Immunological factors
Because immunological factors operate at almost every step in the human reproductive
process, antibodies-induced damage to gametes is a major cause of immunological infertility.
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Lifestyle and environmental factors [17], including smoking, can affect gamete, leading to
subfertility/infertility
3.2.9. Genital infections
Acute and chronic genital tract infections are well-known causes of infertility in men. Most
diseases of the reproductive system are sexually transmitted diseases (STDs), which lead to
deterioration of spermatogenesis, impairment of sperm function, and/or obstruction of the
seminal tract. Genital tract infections and antisperm antibody formation in men can lead to
immune-mediated infertility in women [18, 19]. A strong association between inflammation
of the male reproductive system and infertility has been reported [20, 21].
3.3. Sexually transmitted infection by Chlamydia trachomatis and Mycoplasma genitalium
3.3.1. Chlamydia trachomatis
It is well studied that chronic prostatitis (CP) due to C. trachomatis (CT) infection has a
significant impact on a couple’s reproductive health [22]. Tissue culture was an early method
for the diagnosis of CT infection. In this method, bacterium was inoculated with specimen,
such as urine, grown on cell monolayers. However, cell culture was too insensitive for
noninvasive samples, such as urine and semen that were also found to be toxic to the growth
and maintenance of the monolayer [23]. Molecular methods, such as in situ hybridization (ISH)
and nucleic acid amplification testing (NAAT), were early methods used. NAATs were more
effective in detecting asymptomatic chlamydial infection on noninvasive samples, such as
urine. ISH was superseded once the NAAT become widely available. In-house, polymerase
chain reaction (PCR) is the first test used to detect C. trachomatis in clinical samples during the
development of NAAT. NAAT is more reliable because of its high sensitivity, whereas ample
variation in the results was observed with in-house PCR [26]. Molecular methods, such as
ligase chain reaction (LCR) and PCR, showed better sensitivities than nonmolecular methods,
such as enzyme immunoassay (EIA) test or direct immunofluorescence (DIF), for detection of
C. trachomatis antigen [25].
Alternatively, sperm can also be used as a sample for all molecular methods. In case of NAAT,
an important issue to be considered in selecting semen as a test specimen is there are more
NAAT inhibitors [25]. Another difficulty in using sperm as a sample is that during ejaculation,
semen may become contaminated with elementary bodies in the urethra, and also the organism
has the ability to adhere to sperm and is not always removed from sperm by density centri‐
fugation prior to intrauterine insemination (IUI) or in vitro fertilization (IVF)/ICSI [25].
3.3.2. CT and male infertility
C. trachomatis can cause urethritis, epididymitis, and orchitis in men, and it is also found to
affect sperm by decreasing sperm motility, deteriorating sperm morphology and viability and
increasing proportion of sperm abnormalities. Nongonococcal urethritis (NGU) is the most
common clinical genital syndrome seen in the male. Both acute and chronic infection can cause
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partial or complete obstruction of sperm transport (oligozoospermia or azoospermia). Chronic
inflammatory changes in the seminiferous tubules in orchitis expected to disrupt the normal
process of spermatogenesis and cause alterations in sperm number and quality [24].
Inflammation may act as a co-factor of infertility. Pressure-induced rupture of the epididymal
duct will disrupt the blood–testis barrier, activate an immunological defense reaction, and
induce the production of antisperm antibodies (ASA) [26]. Kokab et al. found that men infected
with C. trachomatis had lower percent progressive sperm motility, a higher leukocyte count,
and a raised concentration of interleukin (IL)-8 in semen compared with men without infection
[26]. Mazzoli et al., 2010 [26] demonstrated that there is a correlation between C. trachomatis
infection and some important sperm parameters, such as sperm concentration and motility.
The attachment of C. trachomatis to human spermatozoa was first observed immunofluores‐
cence tests and transmission electron microscopy. Sperm penetration tests revealed that
spermatozoa, while progressing forward, can carry chlamydiae attached to them [26].
Chlamydial pathology may alter male fertility since male genital organs are potential targets
for CT [28].
Numerous different causes have been observed to affect the sperm, including reactive oxygen
species (ROS) generation and the induction of sperm apoptosis. Other causes include cigarette
smoking, malignancies, elevated body mass index, insulin-dependent diabetes, drugs, and
increasing male age [26].
3.3.3. Mycoplasma genitalium
MG is a member of Mollicutes class, which is of 0.3 µm in diameter and it lacks a cell wall. MG
is one of the smallest self-replicating organisms usually present in the human genital tract [25].
In 1981, MG was first isolated from the urethra of two men with NGU. MG is considered as
sexually transmitted infection (STI). Even though there is no STI symptoms associated with
MG, there is a strong association found between risky sexual behavior and MG infection. It is
also found to be strongly associated with area-level deprivation and ethnicity having high
range of sexual risk behaviors. Sonnenberg et al [29] in 2015 reported high prevalence of MG
infection in the United Kingdom at 2.1% in men aged 25–34 years, whereas in women,
prevalence peaked at 2.4% in 16–19 years old and decreased with age.
3.3.4. MG and male infertility
It is suggested that 15% of male infertility is related to genital tract infection. The prevalence
of MG in male of infertile couples found to be higher than normal. The impact of MG infection
on male infertility remains unclear.
3.4. Urinary tract infection by Streptococcus faecalis
The incidence of oligozoospermia and teratozoospermia was significantly (P<0.05) higher in
men whose semen samples contained S. faecalis [30]. Enterococcus faecalis are associated with
poorer semen quality and may warrant treatment [31].
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3.5. Hepatitis B viral infection leading to infertility
Hepatitis B virus (HBV) belongs to the class of Hepadnaviridae has a partially double-stranded
DNA. HBV is 42 nm in size, and it contains a surface antigen called hepatitis B surface antigen
(HBsAg) and the lipoprotein coat [49]. HBV found to be in the blood either in free form, which
is predominate, or a viral particle bound protein form [32].
HBV infection is one of the threatening viral infections causing liver diseases in patients.
According to Ocama et al (2005), approximately 2 billion people worldwide have been infected
with HBV, and around 400 million live with chronic infection [33]. China, with a prevalence
of 9%, has the highest rate of HBV infection in the world. The prevalence of HBV infections in
the Netherlands is 2.2% in 184 men [34]. More than 300 million people in the world are affected
with chronic HBV [35].
Hepatitis is an inflammation of the liver, initially recognized as an illness causing jaundice.
There were two types of hepatitis: infectious/epidemic hepatitis and serum hepatitis. The
HBsAg is responsible for serum hepatitis, which is an envelope protein present in HBV.
Epidemic hepatitis is caused by hepatitis A virus (HAV). There are other viruses, namely
hepatitis C virus (HCV), hepatitis delta virus (HDV), and hepatitis E virus (HDV) [36].
3.5.1. HBV and male infertility
Hepatitis viruses may cause diseases, which can be acute or chronic [37]. HBV antigens were
detected in human semen [38], and it is well established that this biological fluid is a vector
for the spread of HBV [39, 40]. There is an evidence that HBV can be transmitted via germ line
[41]. The genital tract may act as a reservoir and this infection may get transmitted sexually.
HBV infection was found to be associated with reduced sperm function [42], instability of
sperm chromosome, and impaired sperm viability and normal morphology. Recently, HBV
DNA and RNA was detected in oocytes and embryos from HBV discordant couples, confirm‐
ing the possibility of vertical transmission of HBV via germ line during IVF. However, the
impact of HBV infection on pregnancy rate and live birth rate is still controversial.
3.6. Small pox, mumps, measles, and tuberculosis infections leading to infertility
Mumps is a condition caused by an RNA virus of the paramyxovirus group. In men, orchitis
is the most common complication. Orchitis develops in 5–37% of all adult patients infected
with mumps [43]. This causes testicular atrophy in 40–70% of patients with orchitis [44].
Orchitis can be unilateral or bilateral. Bilateral orchitis leads to oligospermia and testicular
atrophy in 13% of those patients [45].
4. Symptoms, diagnosis and treatment of the infection
CP due to CT infection is found to have a significant impact on young male fertility. The main
challenge in the chlamydial infection is up to 50% men have asymptomatic infection [46]. Many
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young people at risk for of CT infection may not seek sexual health care due to the asympto‐
matic nature of the bacterial infection [47]. HBV infection symptoms include nausea, anorexia,
vomiting, flu-like complaints, fatigue, vasculitis, immune complex nephritis, and polyarteritis
nodosa. There are approximately 5 % of adults (especially men) develop chronic HBV infection,
which is often asymptomatic [32].
4.1. Diagnosis
MG can be found using real-time PCR technique or cell culture. MG culture is time consuming
and slow process, and it requires cocultivation in Vero or equivalent cells [26]. Acute HBV
infection has an incubation period of 6 weeks to several months. Most of the infected adults
will show elevations in Alanine aminotransferase (ALT). Patients with acute HBV infection
are mostly seropositive for anti-HBc-IgM antibody, and hepatitis B e antigen (HBeAg) marker
correlates with high infectivity. The presence of antibody to HBeAg (anti HBe) shows a less
infectious state and also HBV-DNA in serum or plasma indicates active HBV infection [50].
4.2. Treatment
Antibiotic therapy in the eradication of C. trachomatis infection does not always result in recovery
of semen quality. Prulifloxacin is a drug used to treat patients with CP. Combination of antibiotic
drugs and phytotherapeutic agents, such as FERTIMEV, can improve the clinical efficacy of
prulifloxacin. l-arginine, l-carnitine, and acetyl-l-carnitine are found to be effective in increas‐
ing semen quality, can stimulate the activity of endothelial nitric oxide (NO) synthase, and can
enhance sperm motility and function. NO synthase appears to be involved in sperm motility,
metabolism, and capacitation. l-arginine in spermatozoa is a source of NO [29].
Based on Centers for Disease Control and Prevention and the Australasian Sexual Health
Alliance, 1 g of azithromycin is generally recommended as standard treatment for MG due to
its superior cell penetration efficiency. There is an association between MG organism load and
azithromycin treatment failure [50]. However there is also an evidence of azithromycin,
treatment failure is found due to macrolide resistance mutations. Single nucleotide polymor‐
phisms (SNPs) in region V of the 23S rRNA gene of MG were found to be strongly associated
with increased MICs to azithromycin in clinical isolates and treatment failure [28]. Moxiflox‐
acin, doxycycline, gatifloxacin, and sitafloxacin are used as second-line treatment for MG [48].
However, its considerable expense and risk of serious adverse events, including hepatotoxic‐
ity, make this agent unsuitable for initial treatment. Recent study shows that single-dose
azithromycin therapy is better than doxycycline therapy in the treatment of MG [51].
Lamivudine, one of the novel antiviral agents, is a deoxycytosine analog, which inhibits HBV
DNA synthesis and suppresses serum HBV DNA levels in chronic hepatitis B (CH-B) patients.
A significant enhancement in CD4-mediated T cell response to HBV nucleocapsid antigen was
detectable after lamivudine treatment. One of the most effective treatments for CH-B is
interferon (IFN) therapy [35].
Active vaccination is highly effective in preventing HBV infection. Active prophylaxis is a
recombinant vaccine. Recombivax HB and Engerix-B are the commercial products available
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[32]. Successful vaccination strategies have led to significant decrease in HBV prevalence [36].
In case of adult patients, 90% of them recover from HBV infection. However, 90% HBV-affected
children ≤4 years of age develop chronic infection [32].
5. Conclusion
Microbiota refers to the microorganisms present in a particular site. Microbiota when is
disrupted can cause infection on that site. Male genital tract infections are one of the reasons
for male infertility, which can be prevented by proper sanitation. Proper precaution and
awareness should be exercised among population.
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